Gilead Sciences Inc (GILD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | GILD | AMGN | BMY | ||
| Company | Gilead Sciences Inc | Amgen Inc | Bristol-Myers Squibb Company | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | ||
| Open | 136.85 | 355.66 | 59.61 | ||
| High | 137.47 | 355.66 | 59.69 | ||
| Low | 134.10 | 347.80 | 58.37 | ||
| Latest | 134.25 | 348.77 | 58.54 | ||
| Change | -2.63 | -4.39 | -0.89 | ||
| % Change | -1.92% | -1.24% | -1.50% | ||
| Volume | 5,647,100 | 2,274,800 | 7,909,200 | ||
| 20-Day Average Volume | 6,326,585 | 2,660,480 | 13,869,300 | ||
| Previous Close | 136.88 | 353.16 | 59.43 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 143.03 | 363.69 | 59.57 | ||
| 20-Day Raw Stochastic | 0.90% | 8.24% | 32.47% | ||
| 20-Day Relative Strength | 39.01 | 43.14 | 49.19 | ||
| Weighted Alpha | +21.27 | +17.01 | +8.67 | ||
| Today's Opinion | 40% Buy | 56% Buy | 56% Buy | ||
| Previous Opinion | 56% Buy | 56% Buy | 72% Buy | ||
| Last Month's Opinion | 88% Buy | 100% Buy | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -2.16% since 03/20/26 | +0.28% since 03/20/26 | +1.84% since 03/20/26 | ||
| Low | 134.10 on 03/27/26 | 345.80 on 03/24/26 | 56.45 on 03/24/26 | ||
| High | 140.41 on 03/25/26 | 358.00 on 03/25/26 | 59.69 on 03/27/26 | ||
| 1-Month | |||||
| %Chg | -9.87% since 02/27/26 | -10.15% since 02/27/26 | -6.14% since 02/27/26 | ||
| Low | 134.10 on 03/27/26 | 344.95 on 03/20/26 | 56.45 on 03/24/26 | ||
| High | 150.77 on 03/02/26 | 391.29 on 03/02/26 | 62.89 on 03/02/26 | ||
| 3-Month | |||||
| %Chg | +7.66% since 12/26/25 | +4.76% since 12/26/25 | +7.14% since 12/26/25 | ||
| Low | 116.88 on 01/05/26 | 318.21 on 01/05/26 | 52.06 on 01/05/26 | ||
| High | 157.29 on 02/11/26 | 391.29 on 03/02/26 | 62.89 on 03/02/26 | ||
| 6-Month | |||||
| %Chg | +19.76% since 09/26/25 | +27.76% since 09/26/25 | +32.68% since 09/26/25 | ||
| Low | 108.46 on 10/02/25 | 270.67 on 09/29/25 | 42.52 on 10/29/25 | ||
| High | 157.29 on 02/11/26 | 391.29 on 03/02/26 | 62.89 on 03/02/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 166,634,064 | 188,010,736 | 119,523,168 | ||
| Shares Outstanding, K | 1,241,222 | 539,068 | 2,041,735 | ||
| Annual Sales | 29,443,000,000 | 36,751,000,000 | 48,194,000,000 | ||
| Annual Net Income | 8,510,000,000 | 7,711,000,000 | 7,054,000,000 | ||
| Last Quarter Sales | 7,925,000,000 | 9,866,000,000 | 12,502,000,000 | ||
| Last Quarter Net Income | 2,183,000,000 | 1,333,000,000 | 1,086,000,000 | ||
| 60-Month Beta | 0.37 | 0.45 | 0.26 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 1.86 on 02/10/26 | 5.29 on 02/03/26 | 1.26 on 02/05/26 | ||
| Latest Earnings Date | 04/23/26 | 05/07/26 | 04/30/26 | ||
| Most Recent Dividend | 0.820 on 03/13/26 | 2.520 on 02/13/26 | 0.630 on 01/02/26 | ||
| Next Ex-Dividends Date | 03/13/26 | 05/15/26 | 04/02/26 | ||
| Ratios | |||||
| Price/Earnings ttm | 16.80 | 16.16 | 9.66 | ||